1. Home
  2. For Industry
  3. CEO Forums: An FDA Listening Tour to Engage Pharmaceutical and Biotech CEOs
  1. For Industry

CEO Forums: An FDA Listening Tour to Engage Pharmaceutical and Biotech CEOs

Image
CEO Forums: FDA National Listening Tour with Pharmaceutical and Biotech CEOs

The U.S. Food and Drug Administration is conducting a national listening tour to meet directly with pharmaceutical and biotech CEOs. Held in major innovation hubs across the country, the CEO Forums will be led by FDA Commissioner Marty A. Makary, M.D., M.P.H., and Director of FDA’s Center for Drug Evaluation and Research, George Tidmarsh, M.D., Ph.D.  

These forums are part of a new initiative to gather direct input from biotechnology and pharmaceutical leaders on how the FDA can modernize its regulatory framework to better support innovation and patient access to safe and effective therapies.

Please use the registration form below to express your interest in attending one of the CEO forums being held across the country.  

Requirements

  • Registrants must have at least one active Investigational New Drug (IND), New Drug Application (NDA) or Biologics License Application (BLA) on file with the FDA.
  • While participation by a CEO is preferred, registration is also open to the company's Chief Scientific Officer or a Chief Medical Officer or Head of Research and Development.  
  • Interested companies should only register for one CEO Forum.
  • Final eligibility for attendance will be determined by the FDA.

Dates & Locations

  • FDA Silver Spring, MD - June 5, 2025.
  • San Francisco, CA - June 12, 2025.
  • San Diego, CA - June 13, 2025.
  • Boston, MA - June 17, 2025.
  • New York, NY - July 30, 2025.
  • Raleigh, NC – Tentatively scheduled for September 15, 2025. This meeting has reached its capacity and registration is now closed.
  • Atlanta, GA - September 26, 2025. This meeting has reached its capacity and registration is now closed.

Upon registration, FDA will provide additional details of specific locations and times to each accepted participant.

 

“These CEO Forums are a chance for the FDA to listen and gather feedback from those at the front lines of discovery. We are committed to strengthening a regulatory environment that enables breakthroughs to reach patients faster, while upholding the highest standards of safety and scientific integrity.”  

- FDA Commissioner Marty A. Makary, M.D., M.P.H.



Back to Top